These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9849033)

  • 1. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M; Saraf ML
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG; Nordin BE; Chatterton BE
    Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
    Gennari C; AgnusDei D; Gonnelli S; Nardi P
    Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nandrolone decanoate on bone mass in established osteoporosis.
    Passeri M; Pedrazzoni M; Pioli G; Butturini L; Ruys AH; Cortenraad MG
    Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
    Flicker L; Hopper JL; Larkins RG; Lichtenstein M; Buirski G; Wark JD
    Osteoporos Int; 1997; 7(1):29-35. PubMed ID: 9102059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
    Hassager C; Jensen LT; Pødenphant J; Thomsen K; Christiansen C
    Calcif Tissue Int; 1994 Jan; 54(1):30-3. PubMed ID: 8118750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
    Johansen JS; Hassager C; Pødenphant J; Riis BJ; Hartwell D; Thomsen K; Christiansen C
    Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
    Jerome CP; Power RA; Obasanjo IO; Register TC; Guidry M; Carlson CS; Weaver DS
    Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
    Hassager C; Riis BJ; Pødenphant J; Christiansen C
    Maturitas; 1989 Dec; 11(4):305-17. PubMed ID: 2693918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nandrolone decanoate for men with osteoporosis.
    Hamdy RC; Moore SW; Whalen KE; Landy C
    Am J Ther; 1998 Mar; 5(2):89-95. PubMed ID: 10099043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment.
    Huang RY; Miller LM; Carlson CS; Chance MR
    Bone; 2002 Mar; 30(3):492-7. PubMed ID: 11882463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C; Agnusdei D; Gonnelli S
    Minerva Endocrinol; 1989; 14(1):69-74. PubMed ID: 2659955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.
    Lyritis GP; Androulakis C; Magiasis B; Charalambaki Z; Tsakalakos N
    Bone Miner; 1994 Dec; 27(3):209-17. PubMed ID: 7696887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin.
    Hartwell D; Hassager C; Overgaard K; Riis BJ; Pødenphant JR; Christiansen C
    Acta Endocrinol (Copenh); 1990 Jun; 122(6):715-21. PubMed ID: 2375235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.
    Aerssens J; Van Audekercke R; Geusens P; Schot LP; Osman AA; Dequeker J
    Calcif Tissue Int; 1993 Oct; 53(4):269-77. PubMed ID: 8275356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogens, anabolic steroids and postmenopausal osteoporosis: what are the facts?].
    Birkenhäger JC
    Ned Tijdschr Geneeskd; 1991 Jun; 135(22):973-5. PubMed ID: 2062392
    [No Abstract]   [Full Text] [Related]  

  • 17. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S; Rossini M
    Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of nandrolone decanoate on bone mineral content and intestinal absorption of calcium].
    Nuti R; Righi GA; Turchetti V; Vattimo A
    Minerva Med; 1984 Jan; 75(3-4):109-13. PubMed ID: 6366617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
    Johansen KL; Mulligan K; Schambelan M
    JAMA; 1999 Apr; 281(14):1275-81. PubMed ID: 10208142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate.
    Erdtsieck RJ; Pols HA; van Kuijk C; Birkenhäger-Frenkel DH; Zeelenberg J; Kooy PP; Mulder P; Birkenhäger JC
    J Bone Miner Res; 1994 Feb; 9(2):277-83. PubMed ID: 8140941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.